BCL2 and Alzheimer disease: In this study, Aβ1–42 toxicity showed increased Bax protein levels, decreased Bcl-2 protein levels, and an elevated Bax/Bcl-2 ratio, indicating that Aβ1–42 triggers cellular apoptosis in the in vitro AD model.